Suppr超能文献

乳腺癌腋窝淋巴结微转移:免疫组织化学检测及其预后意义

Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance.

作者信息

Trojani M, de Mascarel I, Bonichon F, Coindre J M, Delsol G

出版信息

Br J Cancer. 1987 Mar;55(3):303-6. doi: 10.1038/bjc.1987.59.

Abstract

Metastases to axillary lymph nodes is an important factor in predicting prognosis and survival in primary operable carcinoma of the breast. A series of post mastectomy lymph nodes (150 cases) was selected in this retrospective study, in which the initial diagnosis had been no metastases by light microscopy and in which a long follow-up was available (average 10 years). The original H&E sections from these cases were immunostained to detect metastases which might not have been previously appreciated. The study was performed using a cocktail of 5 monoclonal antibodies directed against epithelial antigens. The object was to explore the possibility of detection of occult micrometastases by immunohistochemistry and to evaluate their prognostic significance. Micrometastases with individual cells and cell clusters were readily detected by this technique in 14% of all cases. It also became apparent towards the end of the study that micrometastases could be detected with equal sensitivity by any one of the 5 monoclonal antibodies. Positive staining of malignant cells was found to be more frequent in invasive lobular carcinoma (ILC) than in invasive ductal carcinoma (IDC). However, for the IDC group a striking association was found between micrometastases and both recurrence and survival rate. The ILC sample was considered too small for meaningful interpretation. We recommend the use of immunohistochemical techniques using monoclonal antibodies for the detection of occult metastases in lymph nodes to improve the prediction of recurrence and survival in invasive ductal carcinoma of the breast.

摘要

腋窝淋巴结转移是预测原发性可手术乳腺癌预后和生存的重要因素。在这项回顾性研究中,选取了一系列乳房切除术后淋巴结样本(150例),这些病例最初经光学显微镜检查未发现转移,且有较长的随访时间(平均10年)。对这些病例的原始苏木精-伊红(H&E)切片进行免疫染色,以检测可能先前未被发现的转移灶。该研究使用了5种针对上皮抗原的单克隆抗体混合物。目的是探讨通过免疫组织化学检测隐匿性微转移的可能性,并评估其预后意义。通过该技术在所有病例的14%中很容易检测到单个细胞和细胞簇的微转移。在研究接近尾声时还发现,这5种单克隆抗体中的任何一种都能以相同的敏感性检测到微转移。发现浸润性小叶癌(ILC)中恶性细胞的阳性染色比浸润性导管癌(IDC)更常见。然而,对于IDC组,发现微转移与复发率和生存率之间存在显著关联。ILC样本量过小,无法进行有意义的解读。我们建议使用针对单克隆抗体的免疫组织化学技术来检测淋巴结中的隐匿性转移,以改善对乳腺浸润性导管癌复发和生存的预测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bdd/2001759/1f1d6f940118/brjcancer00514-0072-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验